These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 16510594

  • 1. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.
    Yoon SO, Shin S, Lipscomb EA.
    Cancer Res; 2006 Mar 01; 66(5):2732-9. PubMed ID: 16510594
    [Abstract] [Full Text] [Related]

  • 2. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
    Kassis J, Moellinger J, Lo H, Greenberg NM, Kim HG, Wells A.
    Clin Cancer Res; 1999 Aug 01; 5(8):2251-60. PubMed ID: 10473113
    [Abstract] [Full Text] [Related]

  • 3. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM, Breen K, Rødland MS, Haslekås C, Stang E, Madshus IH.
    Mol Cancer Res; 2009 Feb 01; 7(2):275-84. PubMed ID: 19208749
    [Abstract] [Full Text] [Related]

  • 4. Curcumin inhibition of integrin (alpha6beta4)-dependent breast cancer cell motility and invasion.
    Kim HI, Huang H, Cheepala S, Huang S, Chung J.
    Cancer Prev Res (Phila); 2008 Oct 01; 1(5):385-91. PubMed ID: 19138983
    [Abstract] [Full Text] [Related]

  • 5. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D.
    Cancer Res; 2006 Apr 01; 66(7):3903-11. PubMed ID: 16585219
    [Abstract] [Full Text] [Related]

  • 6. Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.
    Xia W, Bisi J, Strum J, Liu L, Carrick K, Graham KM, Treece AL, Hardwicke MA, Dush M, Liao Q, Westlund RE, Zhao S, Bacus S, Spector NL.
    Cancer Res; 2006 Feb 01; 66(3):1640-7. PubMed ID: 16452223
    [Abstract] [Full Text] [Related]

  • 7. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
    Bremm A, Walch A, Fuchs M, Mages J, Duyster J, Keller G, Hermannstädter C, Becker KF, Rauser S, Langer R, von Weyhern CH, Höfler H, Luber B.
    Cancer Res; 2008 Feb 01; 68(3):707-14. PubMed ID: 18245470
    [Abstract] [Full Text] [Related]

  • 8. Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis.
    Zhou Y, Brattain MG.
    Cancer Res; 2005 Jul 01; 65(13):5848-56. PubMed ID: 15994962
    [Abstract] [Full Text] [Related]

  • 9. ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells.
    Contessa JN, Abell A, Valerie K, Lin PS, Schmidt-Ullrich RK.
    Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):851-8. PubMed ID: 16751066
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
    Ma C, Lin H, Leonard SS, Shi X, Ye J, Luo J.
    Oncogene; 2003 Aug 14; 22(34):5281-90. PubMed ID: 12917629
    [Abstract] [Full Text] [Related]

  • 11. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
    Zhan L, Xiang B, Muthuswamy SK.
    Cancer Res; 2006 May 15; 66(10):5201-8. PubMed ID: 16707444
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
    Zhao YH, Zhou M, Liu H, Ding Y, Khong HT, Yu D, Fodstad O, Tan M.
    Oncogene; 2009 Oct 22; 28(42):3689-701. PubMed ID: 19668225
    [Abstract] [Full Text] [Related]

  • 13. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y, Li X, Jiang J, Frank SJ.
    Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991
    [Abstract] [Full Text] [Related]

  • 14. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
    Spangenberg C, Lausch EU, Trost TM, Prawitt D, May A, Keppler R, Fees SA, Reutzel D, Bell C, Schmitt S, Schiffer IB, Weber A, Brenner W, Hermes M, Sahin U, Türeci O, Koelbl H, Hengstler JG, Zabel BU.
    Cancer Res; 2006 Apr 01; 66(7):3715-25. PubMed ID: 16585198
    [Abstract] [Full Text] [Related]

  • 15. Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways.
    Niu G, Carter WB.
    Cancer Res; 2007 Feb 15; 67(4):1487-93. PubMed ID: 17308086
    [Abstract] [Full Text] [Related]

  • 16. PTH-related protein upregulates integrin alpha6beta4 expression and activates Akt in breast cancer cells.
    Shen X, Falzon M.
    Exp Cell Res; 2006 Nov 15; 312(19):3822-34. PubMed ID: 16965770
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of ErbB2 impairs ligand-dependent downregulation of epidermal growth factor receptors via a post-transcriptional mechanism.
    Huang G, Chantry A, Epstein RJ.
    J Cell Biochem; 1999 Jul 01; 74(1):23-30. PubMed ID: 10381258
    [Abstract] [Full Text] [Related]

  • 18. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
    Berquin IM, Pang B, Dziubinski ML, Scott LM, Chen YQ, Nolan GP, Ethier SP.
    Oncogene; 2005 Apr 28; 24(19):3177-86. PubMed ID: 15735691
    [Abstract] [Full Text] [Related]

  • 19. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
    Zheng Y, Izumi K, Yao JL, Miyamoto H.
    Endocr Relat Cancer; 2011 Aug 28; 18(4):451-64. PubMed ID: 21613411
    [Abstract] [Full Text] [Related]

  • 20. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A, Di Domenico M, Castoria G, Nanayakkara M, Lombardi M, de Falco A, Bilancio A, Varricchio L, Ciociola A, Auricchio F.
    Cancer Res; 2005 Nov 15; 65(22):10585-93. PubMed ID: 16288052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.